| Primary |
| Hypertension |
49.7% |
| Blood Pressure |
7.4% |
| Atrial Fibrillation |
5.2% |
| Hypercholesterolaemia |
4.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Cardiac Failure |
3.0% |
| Pain |
3.0% |
| Blood Pressure Abnormal |
2.8% |
| Essential Hypertension |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Asthma |
2.2% |
| Diabetes Mellitus |
2.2% |
| Cardiac Failure Congestive |
1.7% |
| Anxiety |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Gout |
1.5% |
| Nausea |
1.5% |
| Renal Transplant |
1.5% |
| Arrhythmia |
1.3% |
| Atrial Flutter |
1.3% |
|
| Hypertension |
31.5% |
| Renal Failure Acute |
10.5% |
| Cough |
6.1% |
| Renal Failure |
5.0% |
| Angioedema |
3.9% |
| Drug Ineffective |
3.9% |
| Fatigue |
3.3% |
| Ill-defined Disorder |
3.3% |
| Swollen Tongue |
3.3% |
| Blood Pressure Increased |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Drug Hypersensitivity |
2.8% |
| Off Label Use |
2.8% |
| Sexual Dysfunction |
2.8% |
| Swelling Face |
2.8% |
| Tremor |
2.8% |
| Urticaria |
2.8% |
| Vomiting |
2.8% |
| Drug Dose Omission |
2.2% |
| Heart Rate Increased |
2.2% |
|
| Secondary |
| Hypertension |
32.8% |
| Product Used For Unknown Indication |
10.0% |
| Gastrooesophageal Reflux Disease |
9.5% |
| Drug Use For Unknown Indication |
9.2% |
| Dyspepsia |
6.8% |
| Type 2 Diabetes Mellitus |
3.5% |
| Pain |
2.8% |
| Atrial Fibrillation |
2.4% |
| Anxiety |
2.3% |
| Diabetes Mellitus |
2.3% |
| Blood Pressure |
2.2% |
| Cardiac Failure |
2.1% |
| Essential Hypertension |
2.1% |
| Blood Pressure Abnormal |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Osteoarthritis |
1.8% |
| Ill-defined Disorder |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Asthma |
1.6% |
| Cardiomyopathy |
1.6% |
|
| Renal Failure Acute |
9.5% |
| Vomiting |
9.5% |
| Off Label Use |
7.5% |
| Weight Increased |
7.5% |
| Drug Hypersensitivity |
6.5% |
| Hypertension |
6.5% |
| Hypotension |
6.5% |
| Renal Failure |
6.0% |
| Weight Decreased |
6.0% |
| Wrong Drug Administered |
5.5% |
| Somnolence |
3.5% |
| Blood Pressure Increased |
3.0% |
| Completed Suicide |
3.0% |
| Drug Dose Omission |
3.0% |
| Fatigue |
3.0% |
| Pulmonary Embolism |
3.0% |
| Rash |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Hyponatraemia |
2.5% |
| Malaise |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
17.5% |
| Hypertension |
16.9% |
| Diabetes Mellitus |
5.3% |
| Pain |
5.1% |
| Depression |
3.9% |
| Blood Cholesterol Increased |
2.9% |
| Prophylaxis |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Osteoporosis |
2.2% |
| Blood Pressure |
2.1% |
| Arthritis |
2.1% |
| Anxiety |
2.0% |
| Multiple Myeloma |
2.0% |
| Breast Cancer |
1.8% |
| Atrial Fibrillation |
1.8% |
| Sleep Disorder |
1.7% |
| Hormone Replacement Therapy |
1.6% |
|
| Vomiting |
12.6% |
| Myocardial Infarction |
10.4% |
| Weight Decreased |
8.8% |
| Weight Increased |
7.0% |
| Type 2 Diabetes Mellitus |
6.5% |
| Pain |
4.9% |
| Renal Failure |
4.8% |
| Nausea |
4.3% |
| Urinary Tract Infection |
4.3% |
| Pancreatitis |
3.9% |
| Thrombocytopenia |
3.8% |
| Transient Ischaemic Attack |
3.7% |
| Cerebrovascular Accident |
3.5% |
| Drug Ineffective |
3.4% |
| Renal Failure Acute |
3.3% |
| Death |
3.1% |
| Pneumonia |
3.1% |
| Injury |
2.9% |
| Vision Blurred |
2.8% |
| Cardiac Failure Congestive |
2.8% |
|
| Interacting |
| Diabetes Mellitus |
17.4% |
| Parkinson's Disease |
17.4% |
| Hypertension |
13.0% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Fluid Retention |
4.3% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Glomerulonephritis Membranous |
4.3% |
| Hepatitis B |
4.3% |
| Hyperlipidaemia |
4.3% |
| Nephritic Syndrome |
4.3% |
| Portal Hypertension |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Renal Disorder |
4.3% |
| Thrombosis Prophylaxis |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
|
| Drug Interaction |
15.4% |
| Parkinsonism |
15.4% |
| Renal Failure Acute |
15.4% |
| Condition Aggravated |
7.7% |
| Drug Ineffective |
7.7% |
| Hyperkalaemia |
7.7% |
| Hypoglycaemia |
7.7% |
| Metabolic Acidosis |
7.7% |
| Obstructive Airways Disorder |
7.7% |
| Renal Failure |
7.7% |
|
